23 pairs of chromosomes. One unique you.
Experience your ancestry in a new way! Get a breakdown of your global ancestry by percentages, connect with DNA relatives and more.
Get an even more comprehensive understanding of your genetics. Receive 65+ online reports on your ancestry, traits and health - and more.
You are made of cells. And the cells in your body have 23 pairs of chromosomes. Your chromosomes are made of DNA, which can tell you a lot about you. Explore your 23 pairs today.
Find out what your 23 pairs of chromosomes can tell you.
Your DNA analysis is performed in US laboratories that are certified to meet CLIA standardsthe Clinical Laboratory Improvement Amendments of 1988.
A CLIA-certified lab must meet certain quality standards, including qualifications for individuals who perform the test and other standards that ensure the accuracy and reliability of results.
We use leading technology to genotype your DNAa custom Illumina HumanOmniExpress-24 format chip.
Learn more about our process.
Provide your saliva sample from home. Mail it back to our lab in the same kit it came inthe postage is pre-paid.
We bring your genetics to you.
Learn more about how it works.
We hear from thousands of customers around the world who write in to tell us about their 23andMe experienceand the impact it has had on their life.
See stories that inspire us.
Here are just a few of the things people frequently ask about 23andMe. If you don't see your question here, get in touch with us.
23andMe was founded in 2006 to help people access, understand and benefit from the human genome.
We have more than one million genotyped customers around the world.
In 2015, 23andMe was granted authorization by the US Food and Drug Administration (FDA) to market the first direct-to-consumer genetic test.
23andMe offers two Personal Genetic Services: Health + Ancestry and Ancestry. Both services require submitting a saliva sample using our saliva collection kit that you send to the lab for analysis.
Our Health + Ancestry Service examines your genes to tell you about your ancestry, carrier status,* wellness and traits. We analyze, compile and distill the information extracted from your DNA into 65+ reports you can access online and share with family and friends. See full list of reports offered.
Our Ancestry Service helps you understand who you are, where you came from and your family story. We analyze, compile and distill your DNA information into reports on your Ancestry Composition, Haplogroups, Neanderthal Ancestry and provide a DNA Relatives tool to enable you to connect with people who share DNA with you.
If you have the Health + Ancestry Service you have access to the full 23andMe experience. If you only have the Ancestry Service, you can easily upgrade to the Health + Ancestry Service for $125 at any time which gives you access to all 65+ reports on ancestry, carrier status,* wellness and traits. To upgrade, log in to your 23andMe account and navigate to the Settings page. You will receive immediate access to your new health reports.
23andMe is the first and only genetic service available directly to you that includes reports that meet FDA standards for clinical and scientific validity.
Our rigorous quality standards:
You choose how your genetic information is used and shared with others. We tell you how those choices are implemented and how we collect, use and disclose your information.
*Our tests can be used to determine carrier status in adults from saliva collected using an FDA-cleared collection device (OrageneDX model OGD-500.001), but cannot determine if you have two copies of the genetic variant. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.
The Cystic Fibrosis carrier status test is indicated for the detection of 28 variants in the CFTR gene and is most relevant for people of Ashkenazi Jewish, European, and Hispanic/Latino descent. The Sickle Cell Anemia carrier status test is indicated for the detection of the HbS variant in the HBB gene and is most relevant for people of African descent. The carrier status tests related to hereditary hearing loss consist of two tests one indicated for the detection of two variants in the GJB2 gene which is most relevant for people of Ashkenazi Jewish and European descent, and one indicated for the detection of six variants in the SLC26A4 gene.
Get a breakdown of your global ancestry, connect with DNA relatives and more.
Receive 65+ online reports on your ancestry, traits and health - and more.
Your DNA can tell you about your family history. Reports include: Ancestry Composition, Haplogroups, Neanderthal Ancestry
Find and connect with relatives in the 23andMe database who share DNA with you.
If you are starting a family, find out if you are a carrier for an inherited condition. Example reports include: Cystic Fibrosis, Sickle Cell Anemia, Hereditary Hearing Loss
Learn how your genes play a role in your well-being and lifestyle choices. Example reports include: Deep Sleep, Lactose Intolerance, Saturated Fat and Weight
Explore what makes you unique, from food preferences to physical features. Example reports include: Male Bald Spot, Sweet vs. Salty, Unibrow
23andMe is the first and only genetic service available directly to you that includes reports that meet FDA standards for clinical and scientific validity.
23andMe was founded in 2006 to help people access, understand and benefit from the human genome.
We have more than one million genotyped customers around the world. Read more.
See what customers are saying about us. Read more.
You can make a difference by participating in research online, from anywhere. Read more.
We are here to help with your questions. No question is too big or small. Read more.
See the list of important policies below. Click to read more.
Your DNA can tell you about your family history. See sample report. See sample report.
Learn how your genes play a role in your well-being and lifestyle choices. See sample report. See sample report.
Explore what makes you unique, from food preference to physical features. See sample report. See sample report.
If you are starting a family, find out if you are a carrier for an inherited condition. See sample report. See sample report.
1 variant in the SACS gene; relevant for French Canadian descent
1 variant in the SLC12A6 gene; relevant for French Canadian descent
3 variants in the PKHD1 gene
10 variants in the HBB gene; relevant for Cypriot, Greek, Italian, Sardinian descent
1 variant in the BLM gene; relevant for Ashkenazi Jewish descent
2 variants in the PMM2 gene; relevant for Danish descent
28 variants in the CFTR gene; relevant for European, Hispanic/Latino, Ashkenazi Jewish descent
2 variants in the HSD17B4 gene
1 variant in the DLD gene; relevant for Ashkenazi Jewish descent
1 variant in the IKBKAP gene; relevant for Ashkenazi Jewish descent
3 variants in the FANCC gene; relevant for Ashkenazi Jewish descent
1 variant in the BCS1L gene; relevant for Finnish descent
1 variant in the G6PC gene; relevant for Ashkenazi Jewish descent
2 variants in the SLC37A4 gene
3 variants in the ALDOB gene; relevant for European descent
3 variants in the LAMB3 gene
1 variant in the LRPPRC gene; relevant for French Canadian descent
1 variant in the SGCA gene; relevant for Finnish descent
1 variant in the SGCB gene; relevant for Southern Indiana Amish descent
1 variant in the FKRP gene; relevant for European descent
3 variants in the ACADM gene; relevant for Northern European descent
2 variants in the BCKDHB gene; relevant for Ashkenazi Jewish descent
1 variant in the CLN5 gene; relevant for Finnish descent
3 variants in the PPT1 gene; relevant for Finnish descent
3 variants in the SMPD1 gene; relevant for Ashkenazi Jewish descent
1 variant in the NBN gene; relevant for Eastern European descent
2 variants in the GJB2 gene; relevant for Ashkenazi Jewish, European descent
6 variants in the SLC26A4 gene
23 variants in the PAH gene; relevant for Northern European descent
1 variant in the GRHPR gene; relevant for European descent
1 variant in the PEX7 gene
1 variant in the SLC17A5 gene; relevant for Finnish, Swedish descent
1 variant in the HBB gene; relevant for African descent
1 variant in the ALDH3A2 gene; relevant for Swedish descent
4 variants in the HEXA gene; relevant for Ashkenazi Jewish, Cajun descent
4 variants in the FAH gene; relevant for French Canadian, Finnish descent
1 variant in the PCDH15 gene; relevant for Ashkenazi Jewish descent
1 variant in the CLRN1 gene; relevant for Ashkenazi Jewish descent
1 variant in the PEX1 gene
*Our tests can be used to determine carrier status in adults from saliva collected using an FDA-cleared collection device (OrageneDX model OGD-500.001), but cannot determine if you have two copies of the genetic variant. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.
Our product is in English only, and due to the applicable regulations it is only available for customers with shipping addresses in the following countries.
If your country is not listed, visit the International site.
The rest is here:
23andMe - DNA Genetic Testing & Analysis
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021